According to Interfax, the observation of volunteers will be carried out for six months after vaccination.
“Research will begin on the basis of the medical unit 163 of the Federal Medical and Biological Agency (FMBA) in February this year.
300 volunteers will take part in them,” the center told the agency.
Based on the results of the study, a report will be prepared for the Ministry of Health of Russia.
Earlier, the Ministry of Health of Russia issued a permit to the Vector Research Center to conduct clinical trials of the EpiVacCoron-N vaccine in people over 60 years of age.
The end of the tests is scheduled for December 30, 2022.